T1	PROC 46 60	Ensayo clínico
#1	AnnotatorNotes T1	C0008976; Clinical Trials; Research Activity
T2	DISO 102 136	distrés respiratorio tipo COVID-19
T3	PROC 159 243	Ensayo clínico multicéntrico, aleatorizado, controlado, con dos ramas de tratamiento
T4	PROC 249 280	evaluar la seguridad y eficacia
T5	PROC 287 313	administración intravenosa
#2	AnnotatorNotes T5	C0455142; Intravenous therapy; Therapeutic or Preventive Procedure
T6	ANAT 317 356	células mesenquimales troncales adultas
#3	AnnotatorNotes T6	C5400079; Adult human mesenchymal stem cells; Cell
T7	CHEM 82 85	MSC
#4	AnnotatorNotes T7	C1720705; Human mesenchymal stem cell-containing product; Immunologic Factor · Pharmacologic Substance
T8	ANAT 371 385	tejido adiposo
#5	AnnotatorNotes T8	C0001527; Adipose tissue; Tissue
T9	DISO 456 476	Distrés respiratorio
#6	AnnotatorNotes T9	C0035222; Respiratory Distress Syndrome, Adult; Disease or Syndrome | C0748355; Acute respiratory distress; Disease or Syndrome
T10	DISO 490 514	infección por SARS-Cov-2
#7	AnnotatorNotes T10	C5203670; COVID19 (disease); Disease or Syndrome
T11	DISO 607 631	infección por SARS-COV-2
#8	AnnotatorNotes T11	C5203670; COVID19 (disease); Disease or Syndrome
T12	PROC 641 647	RT-PCR
#9	AnnotatorNotes T12	C0599161; Reverse Transcriptase Polymerase Chain Reaction; Molecular Biology Research Technique
T13	DISO 678 696	Fallo respiratorio
#10	AnnotatorNotes T13	C0035229; Respiratory Insufficiency; Pathologic Function
T14	PROC 710 720	intubación
#11	AnnotatorNotes T14	C0021925; Intubation (procedure); Therapeutic or Preventive Procedure
T15	PROC 734 754	ventilación mecánica
#12	AnnotatorNotes T15	C0199470; Mechanical ventilation; Therapeutic or Preventive Procedure
T16	DISO 769 793	infección por SARS-Cov-2
#13	AnnotatorNotes T16	C5203670; COVID19 (disease); Disease or Syndrome
T17	PROC 1504 1525	soporte extracorpóreo
#14	AnnotatorNotes T17	C0015357; Extracorporeal Membrane Oxygenation; Therapeutic or Preventive Procedure
T18	DISO 811 837	distrés respiratorio agudo
T19	DISO 839 876	infiltrado agudo alveolo-intersticial
#15	AnnotatorNotes T19	C0748145; PULMONARY INFILTRATE INTERSTITIAL ALVEOLAR; Disease or Syndrome
T20	ANAT 864 876	intersticial
#16	AnnotatorNotes T20	C0596790; interstitial; Body Location or Region | C2328510; Interstitium; Body Part, Organ, or Organ Component
T21	ANAT 904 924	ventrículo izquierdo
#17	AnnotatorNotes T21	C0225897; Left ventricular structure; Body Part, Organ, or Organ Component | C1269892; Entire left ventricle; Body Part, Organ, or Organ Component
T22	PROC 941 950	ecografía
#18	AnnotatorNotes T22	C0041618; Ultrasonography; Diagnostic Procedure
T23	PROC 1086 1113	prueba de embarazo en orina
#19	AnnotatorNotes T23	C0430056; Urine pregnancy test; Laboratory Procedure
T24	PROC 1178 1219	Consentimiento informado escrito o verbal
#20	AnnotatorNotes T24	C1608381; Consent Mode - Verbal; Health Care Activity (?) + C0811741; Obtain informed written consent; Health Care Activity
T25	DISO 1322 1348	distrés respiratorio agudo
T26	PROC 1388 1410	RT-PCR para SARS-Cov-2
#21	AnnotatorNotes T26	C5244035; SARS-CoV-2 PCR test; Laboratory Procedure | C5541700; PCR for SARS-CoV-2; Laboratory Procedure
T27	DISO 1423 1442	Fallo multiorgánico
#22	AnnotatorNotes T27	C0026766; Multiple Organ Failure; Pathologic Function
T28	ANAT 1453 1460	órganos
#23	AnnotatorNotes T28	C0178784; Organ; Body Part, Organ, or Organ Component | C1280836; Entire body organ; Body Part, Organ, or Organ Component
T29	DISO 1465 1483	Fallo respiratorio
#24	AnnotatorNotes T29	C0035229; Respiratory Insufficiency; Pathologic Function
T30	DISO 1536 1540	EPOC
#25	AnnotatorNotes T30	C0024117; Chronic Obstructive Airway Disease; Disease or Syndrome
T31	PROC 1570 1605	oxigenoterapia crónica domiciliaria
T32	DISO 1711 1729	Enfermedad tumoral
T33	PROC 1741 1767	Tratamiento inmunosupresor
#26	AnnotatorNotes T33	C0021079; Therapeutic immunosuppression; Therapeutic or Preventive Procedure
T34	PROC 1672 1697	medidas contraconceptivas
T35	DISO 1778 1785	Alergia
#27	AnnotatorNotes T35	C1527304; Allergic Reaction; Pathologic Function
T36	DISO 1788 1805	hipersensibilidad
#28	AnnotatorNotes T36	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T37	DISO 1852 1879	trombosis venosa o pulmonar
T38	ANAT 1871 1879	pulmonar
#29	AnnotatorNotes T38	C0034052; Pulmonary artery structure; Body Part, Organ, or Organ Component | C1269026; Entire pulmonary artery; Body Part, Organ, or Organ Component
T39	PROC 1928 1944	ensayos clínicos
#30	AnnotatorNotes T39	C0008976; Clinical Trials; Research Activity
T40	PROC 64 85	administración de MSC
T41	DISO 422 430	COVID-19
#31	AnnotatorNotes T41	C5203670; COVID19 (disease); Disease or Syndrome
T42	ANAT 655 675	muestra respiratoria
T43	ANAT 856 863	alveolo
#32	AnnotatorNotes T43	C1515933; Alveolus; Body Part, Organ, or Organ Component
T44	PROC 1029 1038	PaO2/FiO2
#33	AnnotatorNotes T44	C3897988; Partial Pressure Arterial Oxygen to Fraction Inspired Oxygen Ratio Measurement; Laboratory Procedure
T45	DISO 895 924	fallo de ventrículo izquierdo
T46	ANAT 1108 1113	orina
#34	AnnotatorNotes T46	C0042036; Urine; Body Substance
T47	PROC 1527 1531	ECMO
#35	AnnotatorNotes T47	C0015357; Extracorporeal Membrane Oxygenation; Therapeutic or Preventive Procedure
T48	CHEM 1753 1767	inmunosupresor
#36	AnnotatorNotes T48	C0021081; Immunosuppressive Agents; Immunologic Factor · Pharmacologic Substance
T49	ANAT 1862 1868	venosa
#37	AnnotatorNotes T49	C0042449; Veins; Body Part, Organ, or Organ Component | C1278960; Entire vein; Body Part, Organ, or Organ Component
T50	Date 13 17	2020
T51	LIVB 88 97	pacientes
#38	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T52	Route 302 313	intravenosa
#39	AnnotatorNotes T52	C1522726; Intravenous Route of Drug Administration; Functional Concept
T54	LIVB 403 421	pacientes críticos
#40	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group + C0815272; critical population; Population Group
T55	LIVB 543 567	Pacientes de ambos sexos
#41	AnnotatorNotes T55	C0030705; Patients; Patient or Disabled Group + C0025266; Male population group; Population Group + C0043210; Woman; Population Group
T56	Age 570 588	Mayores de 18 años
T58	Neg_cue 877 879	no
T59	PROC 953 977	parámetros hemodinámicos
#42	AnnotatorNotes T59	C4082936; Hemodynamic Monitoring; Health Care Activity (?)
T60	LIVB 1051 1073	Mujeres en edad fértil
#43	AnnotatorNotes T60	C4324275; Woman of childbearing potential; Population Group
T61	Age 1062 1073	edad fértil
T64	Neg_cue 1114 1122	negativa
T65	LIVB 1234 1242	paciente
#44	AnnotatorNotes T65	C0030705; Patients; Patient or Disabled Group
T66	LIVB 1249 1268	representante legal
#45	AnnotatorNotes T66	C4288823; Legal Representative for the Study; Human
T67	Neg_cue 1353 1355	no
T68	LIVB 1373 1383	SARS-Cov-2
#46	AnnotatorNotes T68	C5203676; SARS-CoV-2; Virus
T69	LIVB 1400 1410	SARS-Cov-2
#47	AnnotatorNotes T69	C5203676; SARS-CoV-2; Virus
T70	Neg_cue 1411 1419	negativa
T71	Duration 1585 1592	crónica
#48	AnnotatorNotes T71	C0205191; chronic; Temporal Concept
T72	PHYS 1609 1617	Embarazo
#49	AnnotatorNotes T72	C0032961; Pregnancy; Organism Function
T73	PHYS 1619 1628	lactancia
#50	AnnotatorNotes T73	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T74	LIVB 1632 1639	mujeres
#51	AnnotatorNotes T74	C0043210; Woman; Population Group
T76	Age 1647 1658	edad fértil
T78	Neg_cue 1663 1665	no
T79	Duration 1883 1901	los últimos 3 años
T80	Duration 1953 1964	los 3 meses
T81	PHYS 110 122	respiratorio
#52	AnnotatorNotes T81	C0035203; Respiration; Physiologic Function
T82	PHYS 464 476	respiratorio
#53	AnnotatorNotes T82	C0035203; Respiration; Physiologic Function
T83	PHYS 684 696	respiratorio
#54	AnnotatorNotes T83	C0035203; Respiration; Physiologic Function
T84	PHYS 819 831	respiratorio
#55	AnnotatorNotes T84	C0035203; Respiration; Physiologic Function
T85	PHYS 1096 1104	embarazo
#56	AnnotatorNotes T85	C0032961; Pregnancy; Organism Function
T86	PHYS 1330 1342	respiratorio
#57	AnnotatorNotes T86	C0035203; Respiration; Physiologic Function
T87	PHYS 1471 1483	respiratorio
#58	AnnotatorNotes T87	C0035203; Respiration; Physiologic Function
T62	LIVB 783 793	SARS-Cov-2
#59	AnnotatorNotes T62	C5203676; SARS-CoV-2; Virus
T63	LIVB 621 631	SARS-COV-2
#60	AnnotatorNotes T63	C5203676; SARS-CoV-2; Virus
T57	LIVB 504 514	SARS-Cov-2
#61	AnnotatorNotes T57	C5203676; SARS-CoV-2; Virus
T53	Quantifier_or_Qualifier 1985 1994	de inicio
T75	PROC 1978 1984	visita
#63	AnnotatorNotes T75	C1512346; Patient Visit; Health Care Activity
A1	Assertion T69 Negated
A2	Assertion T68 Negated
A3	Assertion T85 Negated
A4	Population_data T60 Age
A5	Assertion T45 Negated
A8	Assertion T34 Negated
A7	Status T33 History_of
A9	Status T48 History_of
A10	Status T36 History_of
A11	Status T35 History_of
A12	Status T37 History_of
#64	AnnotatorNotes T4	C0511730; Identify product efficacy and safety issues; Health Care Activity
#65	AnnotatorNotes T42	C0444279; Respiratory sample; Body Substance 
#66	AnnotatorNotes T18	C0748355; Acute respiratory distress; Disease or Syndrome
#67	AnnotatorNotes T25	C0748355; Acute respiratory distress; Disease or Syndrome
#68	AnnotatorNotes T34	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
#69	AnnotatorNotes T37	C0042487; Venous Thrombosis; Pathologic Function + C0151946; Pulmonary thrombosis; Pathologic Function 
R1	Negation Arg1:T78 Arg2:T34	
R2	Negation Arg1:T58 Arg2:T45	
R3	Negation Arg1:T64 Arg2:T85	
R4	Negation Arg1:T67 Arg2:T68	
R5	Negation Arg1:T70 Arg2:T69	
R6	Used_for Arg1:T7 Arg2:T40	
R7	Experiences Arg1:T51 Arg2:T40	
R8	Experiences Arg1:T51 Arg2:T2	
R9	Experiences Arg1:T51 Arg2:T81	
#62	AnnotatorNotes T2	C5419164; COVID-19-Associated Acute Respiratory Distress Syndrome; Disease or Syndrome (?)
R12	Has_Route_or_Mode Arg1:T6 Arg2:T52	
T77	Quantifier_or_Qualifier 368 398	de tejido adiposo y expandidas
R13	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T77	
T89	Quantifier_or_Qualifier 357 367	alogénicas
#70	AnnotatorNotes T89	C1515895; Allogeneic; Qualitative Concept
R15	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T89	
R16	Experiences Arg1:T54 Arg2:T5	
R17	Experiences Arg1:T54 Arg2:T41	
R18	Causes Arg1:T10 Arg2:T9	
R20	Causes Arg1:T57 Arg2:T10	
R21	Causes Arg1:T63 Arg2:T11	
R23	Location_of Arg1:T42 Arg2:T12	
R25	Before Arg1:T14 Arg2:T15	
R26	Causes Arg1:T16 Arg2:T13	
R27	Causes Arg1:T62 Arg2:T16	
R29	Location_of Arg1:T43 Arg2:T19	
R30	Location_of Arg1:T20 Arg2:T19	
R31	Overlap Arg1:T19 Arg2:T45	
R33	Overlap Arg1:T18 Arg2:T45	
R34	Location_of Arg1:T21 Arg2:T45	
T90	Result_or_Value 1039 1048	<200 mmHg
R37	Has_Result_or_Value Arg1:T44 Arg2:T90	
R38	Has_Quantifier_or_Qualifier Arg1:T75 Arg2:T53	
T91	Observation 1905 1944	Participación en otros ensayos clínicos
R39	Overlap Arg1:T39 Arg2:T80	
R40	Has_Duration_or_Interval Arg1:T91 Arg2:T80	
R41	Before Arg1:T91 Arg2:T75	
R42	Location_of Arg1:T49 Arg2:T37	
R43	Location_of Arg1:T38 Arg2:T37	
R44	Overlap Arg1:T37 Arg2:T79	
R45	Used_for Arg1:T48 Arg2:T33	
#71	AnnotatorNotes T45	C0023212; Left-Sided Heart Failure; Disease or Syndrome
T92	Quantifier_or_Qualifier 983 996	inicio súbito
#72	AnnotatorNotes T92	C1276802; Sudden onset (attribute); Temporal Concept
R46	Has_Quantifier_or_Qualifier Arg1:T45 Arg2:T92	
R47	Has_Age Arg1:T60 Arg2:T61	
R48	Experiences Arg1:T60 Arg2:T23	
R49	Experiences Arg1:T60 Arg2:T85	
R50	Location_of Arg1:T46 Arg2:T23	
T93	CONC 1150 1159	inclusión
#73	AnnotatorNotes T93	C1512693; Inclusion; Qualitative Concept
R51	Overlap Arg1:T85 Arg2:T93	
R52	Overlap Arg1:T23 Arg2:T93	
R54	Causes Arg1:T68 Arg2:T25	
T94	Quantifier_or_Qualifier 1444 1452	más de 3
R55	Location_of Arg1:T28 Arg2:T27	
R56	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T94	
T95	Quantifier_or_Qualifier 1484 1490	severo
#74	AnnotatorNotes T95	C1547227; Severe - Severity of Illness Code; Intellectual Product
R58	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T95	
T96	Quantifier_or_Qualifier 1541 1556	moderado-severo
#75	AnnotatorNotes T96	C1299393; Moderate to severe; Qualitative Concept
R59	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T96	
R60	Has_Duration_or_Interval Arg1:T31 Arg2:T71	
#76	AnnotatorNotes T31	C1960973; Home oxygen therapy; Health Care Activity (?)
R61	Experiences Arg1:T74 Arg2:T72	
R62	Experiences Arg1:T74 Arg2:T73	
R63	Has_Age Arg1:T74 Arg2:T76	
R64	Experiences Arg1:T74 Arg2:T34	
T97	Quantifier_or_Qualifier 1698 1706	eficaces
A6	Assertion T97 Negated
#77	AnnotatorNotes T97	C1704419; Effective; Qualitative Concept
R65	Has_Quantifier_or_Qualifier Arg1:T34 Arg2:T97	
R66	Negation Arg1:T78 Arg2:T97	
T98	Quantifier_or_Qualifier 1730 1736	activa
#78	AnnotatorNotes T98	C0679217; Active State; Idea or Concept
#79	AnnotatorNotes T32	C0006826; Malignant Neoplasms; Neoplastic Process
R67	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T98	
#80	AnnotatorNotes T53	C0205265; Initially; Temporal Concept
#81	AnnotatorNotes T40	C1257990; Mesenchymal Stem Cell Transplantation; Therapeutic or Preventive Procedure
A13	Experiencer T51 Patient
A14	Experiencer T54 Patient
A15	Experiencer T55 Patient
A16	Experiencer T60 Patient
A17	Experiencer T65 Patient
A18	Experiencer T66 Other
A19	Experiencer T74 Patient
T88	Result_or_Value 1411 1419	negativa
R10	Has_Result_or_Value Arg1:T26 Arg2:T88	
T99	Result_or_Value 1114 1122	negativa
R11	Has_Result_or_Value Arg1:T23 Arg2:T99	
